SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'AW2'


List of Similar Pattern of Amino Acids


Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1NW3_A_SAMA500_0
(HISTONE
METHYLTRANSFERASE
DOT1L)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
8 / 12 ASP A 161
GLY A 163
VAL A 169
ALA A 188
PHE A 223
LEU A 224
ASN A 241
PHE A 245
AW2  A 502 (-2.9A)
AW2  A 502 (-3.2A)
AW2  A 502 (-4.4A)
AW2  A 502 (-3.6A)
AW2  A 502 (-3.4A)
AW2  A 502 ( 4.3A)
AW2  A 502 (-4.3A)
AW2  A 502 (-4.3A)
0.34A 1nw3A-4er6A:
42.1
1nw3A-4er6A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZZ_A_SAMA635_0
(ACLACINOMYCIN-10-HYD
ROXYLASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 GLY A 163
GLY A 165
GLU A 186
ASP A 222
PHE A 223
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-2.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
0.84A 1qzzA-4er6A:
3.9
1qzzA-4er6A:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QZZ_A_SAMA635_0
(ACLACINOMYCIN-10-HYD
ROXYLASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 GLY A 163
GLY A 165
GLU A 186
PRO A 191
ASP A 222
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-2.6A)
AW2  A 502 ( 4.8A)
AW2  A 502 (-3.5A)
0.74A 1qzzA-4er6A:
3.9
1qzzA-4er6A:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDS_A_SAMA5635_0
(PROTEIN RDMB)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 GLY A 163
GLY A 165
GLU A 186
ASP A 222
PHE A 223
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-2.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
0.85A 1xdsA-4er6A:
10.2
1xdsA-4er6A:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDS_A_SAMA5635_0
(PROTEIN RDMB)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 GLY A 163
GLY A 165
GLU A 186
PRO A 191
ASP A 222
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-2.6A)
AW2  A 502 ( 4.8A)
AW2  A 502 (-3.5A)
0.86A 1xdsA-4er6A:
10.2
1xdsA-4er6A:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDS_B_SAMB9635_0
(PROTEIN RDMB)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 GLY A 163
GLY A 165
GLU A 186
ASP A 222
PHE A 223
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-2.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
0.82A 1xdsB-4er6A:
10.9
1xdsB-4er6A:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDS_B_SAMB9635_0
(PROTEIN RDMB)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 GLY A 163
GLY A 165
GLU A 186
PRO A 191
ASP A 222
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-2.6A)
AW2  A 502 ( 4.8A)
AW2  A 502 (-3.5A)
0.82A 1xdsB-4er6A:
10.9
1xdsB-4er6A:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NXE_B_SAMB303_0
(RIBOSOMAL PROTEIN
L11
METHYLTRANSFERASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 ASP A 161
LEU A 162
GLY A 163
GLY A 165
ASN A 241
AW2  A 502 (-2.9A)
None
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-4.3A)
0.73A 2nxeB-4er6A:
11.9
2nxeB-4er6A:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LM8_D_VIBD223_1
(THIAMINE
PYROPHOSPHOKINASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
4 / 8 HIS A 315
LEU A 143
SER A 268
ASN A 241
None
AW2  A 502 ( 4.4A)
None
AW2  A 502 (-4.3A)
0.95A 3lm8B-4er6A:
2.4
3lm8D-4er6A:
2.2
3lm8B-4er6A:
17.51
3lm8D-4er6A:
17.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QOW_A_SAMA417_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 GLN A 168
ALA A 188
ASP A 222
PHE A 223
ASN A 241
None
AW2  A 502 (-3.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
AW2  A 502 (-4.3A)
0.85A 3qowA-4er6A:
40.9
3qowA-4er6A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QOW_A_SAMA417_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
7 / 12 GLY A 163
VAL A 169
ALA A 188
ASP A 222
PHE A 223
ASN A 241
PHE A 245
AW2  A 502 (-3.2A)
AW2  A 502 (-4.4A)
AW2  A 502 (-3.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
AW2  A 502 (-4.3A)
AW2  A 502 (-4.3A)
0.40A 3qowA-4er6A:
40.9
3qowA-4er6A:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3QOW_A_SAMA417_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 GLY A 163
VAL A 170
ALA A 188
ASP A 222
PHE A 223
AW2  A 502 (-3.2A)
None
AW2  A 502 (-3.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
1.33A 3qowA-4er6A:
40.9
3qowA-4er6A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4B_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
4 / 8 PHE A 159
THR A 177
VAL A 144
VAL A 267
None
None
AW2  A 502 ( 4.9A)
AW2  A 502 (-4.8A)
0.88A 4l4bA-4er6A:
undetectable
4l4bA-4er6A:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V32_A_EF2A151_1
(CEREBLON ISOFORM 4)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
4 / 7 ASN A 241
PRO A 130
PHE A 243
PHE A 272
AW2  A 502 (-4.3A)
None
None
None
1.47A 4v32A-4er6A:
undetectable
4v32A-4er6A:
16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZJ8_A_SUVA2001_1
(HUMAN OX1R FUSION
PROTEIN TO P.ABYSII
GLYCOGEN SYNTHASE)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 ALA A 273
VAL A 293
VAL A 249
MET A 260
PHE A 223
None
None
None
None
AW2  A 502 (-3.4A)
1.23A 4zj8A-4er6A:
4.2
4zj8A-4er6A:
21.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MVS_A_ADNA401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
6 / 7 GLY A 163
GLU A 186
ALA A 188
ASP A 222
PHE A 223
ASN A 241
AW2  A 502 (-3.2A)
AW2  A 502 (-2.6A)
AW2  A 502 (-3.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
AW2  A 502 (-4.3A)
0.50A 5mvsA-4er6A:
41.6
5mvsA-4er6A:
80.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MVS_B_ADNB401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
7 / 8 GLY A 163
GLU A 186
ALA A 188
ASP A 222
PHE A 223
ASN A 241
PHE A 245
AW2  A 502 (-3.2A)
AW2  A 502 (-2.6A)
AW2  A 502 (-3.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
AW2  A 502 (-4.3A)
AW2  A 502 (-4.3A)
0.44A 5mvsB-4er6A:
41.6
5mvsB-4er6A:
80.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YBB_B_SAMB601_0
(TYPE I
RESTRICTION-MODIFICA
TION SYSTEM
METHYLTRANSFERASE
SUBUNIT)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 12 ASP A 161
PRO A 191
LEU A 224
ASN A 241
PHE A 223
AW2  A 502 (-2.9A)
AW2  A 502 ( 4.8A)
AW2  A 502 ( 4.3A)
AW2  A 502 (-4.3A)
AW2  A 502 (-3.4A)
1.39A 5ybbB-4er6A:
undetectable
5ybbB-4er6A:
23.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6NJ9_K_SAMK500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
7 / 12 ASP A 161
GLY A 163
GLY A 165
GLN A 168
ALA A 188
ASP A 222
PHE A 223
AW2  A 502 (-2.9A)
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
None
AW2  A 502 (-3.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
0.61A 6nj9K-4er6A:
35.5
6nj9K-4er6A:
99.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6NJ9_K_SAMK500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
7 / 12 ASP A 161
GLY A 163
GLY A 165
VAL A 169
ALA A 188
ASP A 222
PHE A 223
AW2  A 502 (-2.9A)
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-4.4A)
AW2  A 502 (-3.6A)
AW2  A 502 (-3.5A)
AW2  A 502 (-3.4A)
0.48A 6nj9K-4er6A:
35.5
6nj9K-4er6A:
99.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6NQA_K_SAMK500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
6 / 10 ASP A 161
GLY A 163
GLY A 165
VAL A 169
ASN A 241
PHE A 245
AW2  A 502 (-2.9A)
AW2  A 502 (-3.2A)
AW2  A 502 (-3.5A)
AW2  A 502 (-4.4A)
AW2  A 502 (-4.3A)
AW2  A 502 (-4.3A)
0.55A 6nqaK-4er6A:
33.9
6nqaK-4er6A:
99.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6NQA_K_SAMK500_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
4er6 HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC

(Homo
sapiens)
5 / 10 ASP A 161
GLY A 165
VAL A 169
GLU A 186
PHE A 245
AW2  A 502 (-2.9A)
AW2  A 502 (-3.5A)
AW2  A 502 (-4.4A)
AW2  A 502 (-2.6A)
AW2  A 502 (-4.3A)
0.94A 6nqaK-4er6A:
33.9
6nqaK-4er6A:
99.76